PMC:7696151 / 58174-58434 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1673","span":{"begin":63,"end":68},"obj":"Species"},{"id":"1674","span":{"begin":245,"end":253},"obj":"Species"},{"id":"1680","span":{"begin":108,"end":111},"obj":"Chemical"},{"id":"1681","span":{"begin":168,"end":171},"obj":"Chemical"},{"id":"1691","span":{"begin":46,"end":62},"obj":"Disease"},{"id":"1692","span":{"begin":138,"end":149},"obj":"Disease"}],"attributes":[{"id":"A1673","pred":"tao:has_database_id","subj":"1673","obj":"Tax:9606"},{"id":"A1674","pred":"tao:has_database_id","subj":"1674","obj":"Tax:9606"},{"id":"A1680","pred":"tao:has_database_id","subj":"1680","obj":"MESH:D006886"},{"id":"A1681","pred":"tao:has_database_id","subj":"1681","obj":"MESH:D006886"},{"id":"A1691","pred":"tao:has_database_id","subj":"1691","obj":"MESH:D012859"},{"id":"A1692","pred":"tao:has_database_id","subj":"1692","obj":"MESH:D014987"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Moreover, the salivary flow rate increased in Sjögren syndrome women who received a daily dose of 400 mg of HCQ for 30 weeks [101], while eye dryness was alleviated by HCQ administration (6.5 mg/kg), as demonstrated by a prospective study on 32 patients [102]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T374","span":{"begin":0,"end":260},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Moreover, the salivary flow rate increased in Sjögren syndrome women who received a daily dose of 400 mg of HCQ for 30 weeks [101], while eye dryness was alleviated by HCQ administration (6.5 mg/kg), as demonstrated by a prospective study on 32 patients [102]."}